Biohaven (EXCHANGE:BHVN) Chief Executive Officer Vlad Coric acquired 666,666 common shares in two transactions on November 13, 2025, at a price of $7.50 per share, for a total value of $4,999,995. The ...
Director Gregory Bailey reported purchasing 400,000 common shares of Biohaven Ltd. (NYSE:BHVN) on November 13, 2025. The shares were acquired at a price of $7.50, for a total transaction value of ...
Non-exclusive license providing Solid’s proprietary, next-generation capsid, AAV-SLB101, to Andelyn Biosciences, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback